Ignite Creation Date:
2025-12-24 @ 7:12 PM
Ignite Modification Date:
2026-02-20 @ 6:42 PM
Study NCT ID:
NCT06815003
Status:
RECRUITING
Last Update Posted:
2025-06-27
First Post:
2025-02-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
Sponsor:
Organization: